Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Lexicon Pharmaceuticals, Inc.    LXRX

Financials ($)
Sales 2016 77,3 M
EBIT 2016 -151 M
Net income 2016 -152 M
Debt 2016 -
Yield 2016 -
Sales 2017 114 M
EBIT 2017 -163 M
Net income 2017 -161 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 18,1x
Capi. / Sales 2017 12,3x
Capitalization 1 397 M
More Financials
Lexicon Pharmaceuticals, Inc. engages in discovery and development of breakthrough treatments for human disease.The company primarily focuses on the discovery of the functions and pharmaceutical utility of genes and the use of those gene function discoveries in the discovery and development of... 
More about the company
Surperformance© ratings of Lexicon Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
05/12 LEXICON PHARMACEUTICALS : To Present At The Bank Of America Merrill Lynch 2016 H..
05/12 LEXICON PHARMACEUTICALS : To Report First Quarter 2016 Financial Results On May ..
05/03 LEXICON PHARMACEUTICALS : reports 1Q loss
04/14 LEXICON PHARMACEUTICALS : To Present At The 15th Annual Needham Healthcare Confe..
04/07 LEXICON PHARMACEUTICALS : Submits New Drug Application To FDA For Telotristat Et..
03/17 LEXICON PHARMACEUTICALS : Announces Telotristat Etiprate Data To Be Presented At..
03/10 LEXICON PHARMACEUTICALS : Provides Clinical Pipeline Update and Reports 2015 Fou..
03/08 LEXICON PHARMACEUTICALS : Announces Telotristat Etiprate Data to Be Presented at..
03/01 LEXICON PHARMACEUTICALS : beats 4Q profit forecasts
01/14 LEXICON PHARMACEUTICALS : To Present At The 34th Annual J.P. Morgan Healthcare C..
More news
Sector news : Bio Therapeutic Drugs
05/27 AMGEN : receives positive CHMP opinion to extend indication of Kyprolis
05/27 Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Pos..
05/27 Novartis, Foundation Medicine, Celgene Invest in Healthcare Informatics Firm ..
05/27 Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Scien..
05/27 MEDIVATION : Files Preliminary Consent Revocation Statement
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
2015 SEEKING ALPHA'S BIOTECH WEEKLY : A Gilead Victory, Celladon Crumbles, And More
2015 Lexicon Undervalued As It Approaches A Major Event
2015 Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q1 2015 Results - Earning..
2015 Lexicon Pharmaceuticals EPS in-line, beats on revenue
2015 Lexicon Pharmaceuticals - A Diamond In The Rough?
Duration : Period :
Lexicon Pharmaceuticals, I Technical Analysis Chart | LXRX | US5288721047 | 4-Traders
Full-screen chart
Technical analysis trends LEXICON PHARMACEU...
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions